Michael Morin
Vorsitzender bei NCI Experimental Therapeutics Program
Profil
Michael J.
Morin is currently the Chairman of the Drug Discovery Initiative at the Children's Tumor Foundation and Co-Chairman at the NCI Experimental Therapeutics Program.
He previously worked as the Chief Executive Officer at Supportive Therapeutics, Vice President of Global Research & Development at Pfizer Inc., Chief Scientific Officer at Immunome, Inc., and Chief Scientific Officer at Onkaido Therapeutics LLC.
Morin holds a doctorate degree from the State University of New York at Buffalo and an undergraduate degree from the University of Lowell.
Aktive Positionen von Michael Morin
| Unternehmen | Position | Beginn |
|---|---|---|
| NCI Experimental Therapeutics Program | Vorsitzender | - |
| Children's Tumor Foundation | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Michael Morin
| Unternehmen | Position | Ende |
|---|---|---|
Onkaido Therapeutics LLC
 Onkaido Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Moderna, Inc., Onkaido Therapeutics LLC offers advancement of oncology products for previously undruggable targets and as a superior alternative to existing drug modalities. The company is based in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2015 |
| Supportive Therapeutics | Vorstandsvorsitzender | 01.12.2014 |
| PFIZER, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
| IMMUNOME, INC. | Vorstandsvorsitzender | 01.05.2019 |
Ausbildung von Michael Morin
| State University of New York at Buffalo | Doctorate Degree |
| University of Lowell | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| IMMUNOME, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| Children's Tumor Foundation | Miscellaneous |
| Supportive Therapeutics | |
Onkaido Therapeutics LLC
Onkaido Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Moderna, Inc., Onkaido Therapeutics LLC offers advancement of oncology products for previously undruggable targets and as a superior alternative to existing drug modalities. The company is based in Cambridge, MA. | Health Technology |
| NCI Experimental Therapeutics Program |